4//SEC Filing
Pauls Dietrich John 4
Accession 0001235802-20-000053
CIK 0001401040other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 5:19 PM ET
Size
6.2 KB
Accession
0001235802-20-000053
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2020-06-01+56,000→ 56,000 totalExercise: $4.64Exp: 2030-05-31→ Common Shares (56,000 underlying)
Holdings
- 30,804
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- [F2]Vests in twelve nearly equal quarterly installments commencing on September 1, 2020.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001760123
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 5:19 PM ET
- Size
- 6.2 KB